[1]郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2019,41(1):19-28.
ZHENG RS,SUN KX,ZHANG SW,et al.Report of cancer epidemiology in China,2015[J].Chinese Journal of Oncology,2019,41(1):19-28.
[2]刘巍,郝希山,晋颖,等.4329例手术后食管癌临床病理资料分析[J].中国肿瘤临床,2008,35(5):241-244.
LIU W,HAO XS,JIN Y,et al.Analysis of clinicopathologic features of esophageal cancer patients after surgery-a report of 4329 cases[J].Chinese Journal of Clinical Oncology,2008,35(5):241-244.
[3]ZHAO Q,YU J,MENG X.A good start of immunotherapy in esophageal cancer[J].Cancer Medicine,2019,8(10):4519-4526.
[4]BUSHATI N,COHEN SM.MicroRNA functions[J].Annual Review of Cell and Developmental Biology,2007,23:175-205.
[5]HAN C,SONG Y,LIAN C.MiR-769 inhibits colorectal cancer cell proliferation and invasion by targeting HEY1[J].Medical Science Monitor:International Medical Journal of Experimental and Clinical Research,2018,24:9232-9239.
[6]LUAN PB,JIA XZ,YAO J.MiR-769-5p functions as an oncogene by down-regulating RYBP expression in gastric cancer[J].European Review for Medical and Pharmacological Sciences,2020,24(12):6699-6706.
[7]YANG W,SOARES J,GRENINGER P,et al.Genomics of drug sensitivity in cancer(GDSC):a resource for therapeutic biomarker discovery in cancer cells[J].Nucleic Acids Research,2012,41(D1):D955-D961.
[8]JOHNSON JJ,LOEFFERT AC,STOKES J,et al.Association of salivary microRNA changes with prolonged concussion symptoms[J].JAMA Pediatrics,2018,172(1):65-73.
[9]BUSCH A,BUSCH M,SCHOLZ CJ,et al.Aneurysm miRNA signature differs,depending on disease localization and morphology[J].Int J Mol Sci,2016,17(1):81-91.
[10]CUI JY,LIANG HW,PAN XL,et al.Characterization of a novel panel of plasma microRNAs that discriminates between mycobacterium tuberculosis infection and healthy individuals[J].PLoS One,2017,12(9):e0184113.
[11]WANG L,XU M,LU P,et al.microRNA-769 is downregulated in colorectal cancer and inhibits cancer progression by directly targeting cyclin-dependent kinase 1[J].Onco Targets Ther,2018,11:9013-9025.
[12]CHEN Y,ZHANG W,KADIER A,et al.MicroRNA-769-5p suppresses cell growth and migration via targeting NUSAP1 in bladder cancer[J].Journal of Clinical Laboratory Analysis,2020,34(5):e23193.
[13]QIU HJ,LU XH,YANG SS,et al.MiR-769 promoted cell proliferation in human melanoma by suppressing GSK3B expression[J].Biomedicine & Pharmacotherapy=Biomedecine & Pharmacotherapie,2016,82:117-123.
[14]ROYCHOWDHURY S,CHINNAIYAN AM.Translating cancer genomes and transcriptomes for precision oncology[J].CA Cancer J Clin,2016,66(1):75-88.
[15]PETER JC,GAD G,JAN OK,et al.Pan-cancer analysis of whole genomes[J].Nature,2020,578(7793):82-93.
[16]LIU HY,ZHANG YY,ZHU BL,et al.miR-21 regulates the proliferation and apoptosis of ovarian cancer cells through PTEN/PI3K/AKT[J].European Review for Medical and Pharmacological Sciences,2019,23(10):4149-4155.
[17]WU L,CHEN Y,CHEN Y,et al.Effect of HIF-1α/miR-10b-5p/PTEN on hypoxia-induced cardiomyocyte apoptosis[J].Journal of the American Heart Association,2019,8(18):e011948.
[18]ZHEN L,ZHAO Q,LYU J,et al.miR-301a-PTEN-AKT signaling induces cardiomyocyte proliferation and promotes cardiac repair post-MI[J].Molecular Therapy Nucleic Acids,2020,22:251-262.
[19]MA G,ZHU J,LIU F,et al.Long noncoding RNA LINC00460 promotes the gefitinib resistance of nonsmall cell lung cancer through epidermal growth factor receptor by sponging miR-769-5p[J].DNA and Cell Biology,2019,38(2):176-183.
[20]MA Y,PAN X,XU P,et al.Plasma microRNA alterations between EGFR-activating mutational NSCLC patients with and without primary resistance to TKI[J].Oncotarget,2017,8(51):88529-88536.
[21]FENG Y,HANG W,SANG Z,et al.Identification of exosomal and non-exosomal microRNAs associated with the drug resistance of ovarian cancer[J].Molecular Medicine Reports,2019,19(5):3376-3392.